MEDPAL AI is trading 5.45% down at £5.20 after announcing 1,075,872 new shares for acquisition consideration and management compensation.
- The shares are expected to begin trading on September 9, increasing total voting rights to 779,118,302 and creating modest dilution.
- The September 4 decline followed strong earlier-week gains; broader conditions were mixed, not decisively negative.
- An August Trading Update was published on September 7, but available coverage does not establish it as the cause.